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Abstract
Background: IL8RA and IL8RB, encoded by CXCR1 and CXCR2, are receptors for interleukin (IL)-8 and other CXC
chemokines involved in chemotaxis and activation of polymorphonuclear neutrophils (PMN). Variants at CXCR1 and
CXCR2 have been associated with susceptibility to cutaneous and mucocutaneous leishmaniasis in Brazil. Here we
investigate the role of CXCR1/CXCR2 in visceral leishmaniasis (VL) in India.
Methods: Three single nucleotide polymorphisms (SNPs) (rs4674259, rs2234671, rs3138060) that tag linkage
disequilibrium blocks across CXCR1/CXCR2 were genotyped in primary family-based (313 cases; 176 nuclear families;
836 individuals) and replication (941 cases; 992 controls) samples. Family- and population-based analyses were
performed to look for association between CXCR1/CXCR2 variants and VL. Quantitative RT/PCR was used to
compare CXCR1/CXCR2 expression in mRNA from paired splenic aspirates taken before and after treatment from
19 VL patients.
Results: Family-based analysis using FBAT showed association between VL and SNPs CXCR1_rs2234671 (Z-score =
2.935, P = 0.003) and CXCR1_rs3138060 (Z-score = 2.22, P = 0.026), but not with CXCR2_rs4674259. Logistic
regression analysis of the case-control data under an additive model of inheritance showed association between
VL and SNPs CXCR2_rs4674259 (OR = 1.15, 95%CI = 1.01-1.31, P = 0.027) and CXCR1_rs3138060 (OR = 1.25, 95%CI =
1.02-1.53, P = 0.028), but not with CXCR1_rs2234671. The 3-locus haplotype T_G_C across these SNPs was shown to
be the risk haplotype in both family- (TRANSMIT; P = 0.014) and population- (OR = 1.16, P = 0.028) samples
(combined P = 0.002). CXCR2, but not CXCR1, expression was down regulated in pre-treatment compared to post-
treatment splenic aspirates (P = 0.021).
Conclusions: This well-powered primary and replication genetic study, together with functional analysis of gene
expression, implicate CXCR2 in determining outcome of VL in India.
Background
Visceral leishmaniasis (VL), also known as Kala-azar, is
a life-threatening disease caused by protozoans belong-
ing to Leishmania donovani complex. Population based
epidemiological surveys suggest that 80-90% of indivi-
duals infected with L. donovani show no clinical
symptoms [1-3]. Familial clustering, and the range of
clinical outcomes from asymptomatic to fatal disease
within and between ethnic groups sharing similar risk
factors, support a contribution of host genotype to sus-
ceptibility [4-8]. Resistance to VL, as determined by a
positive antigen-specific DTH response without clinical
symptoms, is ~80% heritable in family-based studies [9].
Genetic variability in ability to mount an innate immune
response, such as in the influx of polymorphonuclear
neutrophils (PMN) during initial hours of infection,
could be important in innate killing of the parasite [10],
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and in providing the cytokine environment in which
parasite-specific T cells are primed [11]. Pro-inflamma-
tory responses elicited by PMN as part of the response
to the bite of the sand fly vector are important in initia-
tion of infection [12]. The arrival and maintenance of
infiltrating cells at bite sites is thought to be mediated
by sand fly-derived factors that mimic a tissue damage
signal and/or activate chemokine/chemokine receptor
pathways [13-15]. Recently [16] we examined the role of
polymorphisms at CXCR1 and CXCR2, which act as
receptors for CXC chemokines that attract PMN to
inflammatory sites, in determining susceptibility to cuta-
neous forms of leishmaniasis caused by infection with L.
braziliensis. We found that cutaneous (CL) and muco-
cutaneous (ML) forms of disease were associated with
opposing alleles for SNP rs2854386 at CXCR1. Studies
in mice [17] show that selective depletion of PMN has a
dramatic effect on the course of infection with L. dono-
vani. Here we use genetic and functional approaches to
evaluate the role of PMN in VL caused by L. donovani
in humans through analysis of the receptors CXCR1,
which is a specific receptor for IL-8 (= CXCL8), and
CXCR2, which is promiscuous in binding a variety of
CXC chemokines (CXCL-1, 2, 3, 5, 6, 7) in addition to
CXCL8.
Methods
The study was conducted in the district of Muzaffar-
pur in Bihar State, India, where VL is highly endemic.
Diagnosis of VL was made on the basis of clinical,
parasitological and serological criteria as described
[18,19]. Further epidemiological and demographic
details relating to the study samples and study site are
described elsewhere [20,21]. Informed written consent
in Hindi was obtained from all participating individuals
and from parents of children under 18 years old.
Approval for the study was provided by the Ethical
Committee of the Institute of Medical Sciences,
Banaras Hindu University, Varanasi, India. Collection
of families was undertaken between 2004 and 2006
while for the case-control study collection was under-
taken during 2009-2010. Table 1 provides details of
primary and replication samples, indicating the num-
ber of extended families that are decomposed into
nuclear families for genetic analysis. For the family-
based primary study, DNA was prepared from buccal
swabs by whole genome amplification as described
[19]. For the replication case-control study, genomic
DNA was extracted from saliva using the Oragene
technology (DNA Genotek, Ontario, Canada).
CXCR1 and CXCR2 lie on a 26 kb region adjacent to
each other on human Chromosome 2q35. CXCR2 is
encoded on the positive strand and lies proximal to
CXCR1 encoded on the negative strand. DNA samples
were genotyped for SNPs (Table 2) CXCR2 (rs4674259)
and CXCR1 (rs3138060) that tag major linkage disequili-
brium (LD) blocks (r2 > 0.8; as determined for available
data from HapMap populations CEU/JPT/CHB; Addi-
tional File 1; Figure S1) across the two genes, as well as
the non-synonymous exon 1 SNP rs2234671 in CXCR1.
For the primary family-based study, SNPs were geno-
typed in 836 individuals using ABI predesigned Taqman
assays (ABI, Mulgrave, Victoria, Australia). For the repli-
cation study, SNPs were genotyped using Sequenom
iPLEX platform (Sequenom, San Diego, CA, USA) for
2022 individuals comprising 990 cases, 1029 controls
(1168 males, 850 females). All 3 SNPs met minimum
quality control checks for call rate (> 99.5%) across all
individuals, and all were in Hardy Weinberg equilibrium
(HWE) in unrelated founders of families and in the con-
trol replication sample. Twelve individuals were
Table 1 Baseline characteristics of (A) families for the
primary sample of Indian multicase VL families, and (B)
the Indian case-control cohorts
(A) Family Structure Number*
No families 137
No nuclear families 176
Nuclear families with 1 affected sib 63
Nuclear families with 2 affected sibs 95
Nuclear families with 3 affected sibs 14
Nuclear families with 4 affected sibs 2
Nuclear families with 5 affected sibs 2
No affected offspring 313
No affected parents 63
Total No affected individuals 394
Total No individuals 836
(B) Case-Control Sample Number
Cases (no.) 958
Male 571
Female 387
Mean age at study encounter ± SD (yr) 31.2 ± 16.7
Range 3-73
Mean age at onset of VL ± SD (yr) 26.8 ± 15.3
Religious Group (no.)
Hindu 850
Muslim 108
Controls (no.) 1015
Male 570
Female 445
Mean age at study encounter ± SD (yr) 31.8 ± 15.9
Religious Group (no.)
Hindu 885
Muslim 130
* Numbers are given for the individuals with DNA available for genotyping
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removed from further analysis where data was missing
for two or more SNPs.
Family-based allelic association tests were performed
within FBAT which is based on the transmission dise-
quilibrium test (TDT) but allows for different genetic
model analyses with incomplete parental data [22,23].
Analyses were performed using an additive model and
under the null hypothesis of “no linkage and no associa-
tion”. Family-based haplotype TDT was performed using
TRANSMIT [24]. Robust tests were performed to take
account of multiple trios within some pedigrees (Table
1). Family based TDT power approximations [25] show
that the 313 VL trios had 49% power to detect an odds
ratio ≥ 1.5 at P = 0.01 for markers with MAF ≥ 0.1. Sin-
gle marker and haplotype association tests for the case-
control sample were carried out using logistic regression
analysis performed in PLINK [26] under an additive
model. Inclusion of caste as a covariate, which we have
shown to provide a good surrogate for genetic substruc-
ture in genome-wide analyses in this population (unpub-
lished data), was used to take account of population
substructure. Religion was also analysed as a covariate.
The 1933 individuals (941 cases and 992 controls)
which passed quality control had 93.5% power to detect
associations with an odds ratio of 1.5 for markers with
MAF ≥ 0.1 at P = 0.01. Nominal two-tailed P-values are
presented throughout, i.e. without correction for multi-
ple testing. Application of a strict Bonferroni correction
for 3 independent (r2 < 0.8) SNPs provides a significance
cut-off of P ≤ 0.017 (i.e. P = 0.05/3). Combined P-values
using Fisher’s Trend Test were calculated using MetaP
[27]. LD plots for D’ and r2 were generated in Haplo-
view [28].
Splenic biopsies were taken as part of routine diagnos-
tic procedure at the Kala Azar Medical Research Centre,
Muzaffarpur, Bihar State, India. Paired pre- (Day-0) and
post- (Day-30) treatment splenic samples were collected
from 19 VL patients in 5xRNA Later (AMBION Inc.,
Austin, Texas, USA) during 2009-2010, transported to
Varanasi at 4°C and stored at -80°C until RNA was iso-
lated. Details regarding age and sex, splenic parasites
and drug administered were recorded for each patient.
Total RNA was isolated using RNeasy tissue kit (Qiagen,
GmbH, Hilden, Germany) according to the
manufacturer’s instructions. Sample quality and integrity
was assessed by ND-2000 spectrophotometer (Thermo
Fischer Scientific, Wilmington, DE, USA) and agarose
(Sigma Aldrich Chemicals, St Louis, MO, USA) gel elec-
trophoresis. 1 μg of RNA was reverse transcribed using
the High Capacity cDNA synthesis kit (Applied Biosys-
tems, Foster City, CA, USA). Taqman predesigned gene
expression assays (CXCR1_Hs00174146_m1 and
CXCR2_Hs01011557_m1) were used to perform expres-
sion studies (7500 HT Real Time PCR system, Applied
Biosystems, Foster City CA, USA) with 18S rRNA (P/N
4319413E) being used as an endogenous control to nor-
malize the expression data. No RT and no template con-
trols were included in each plate. All samples were run
in duplicate. Results were analysed by 7500 software
v.2.0.1 and GraphPad Prism (version 5.00 for Windows,
Graph Pad Software, San Diego California USA, http://
www.graphpad.com). The significance of differences
between pre- and post-treatment groups was determined
using paired Student’s T test. Power calculations showed
that N = 19 paired samples had 92.2% power to detect a
difference in mean values pre- and post-treatment of 0.9
with standard deviation of 0.9 at alpha level 0.01; 98.2%
power at alpha level 0.05.
Results and Discussion
To test the hypothesis that polymorphisms at CXCR1/
CXCR2 might influence susceptibility to VL in India we
initially genotyped 3 tagging SNPs (Table 2) in 176
nuclear families (Table 1) used in our previous studies
[19,21] that contain 313 offspring with VL collected in
the area of Muzaffarpur, Bihar State, India, where L.
donovani is endemic. Using the family-based association
test (FBAT) [29,30] in this primary family dataset (Table
3) we found evidence (nominal P-values ≤ 0.03) for
associations between VL and SNPs CXCR1_rs2234671
(Z-score = 2.935, P = 0.003) and CXCR1_rs3138060 (Z-
score = 2.22, P = 0.026), but not with
CXCR2_rs4674259. Since these two positive markers are
in quite strong LD with each other (Additional File 2;
Figure S2: D’ = 0.84; r2 = 0.46), these associations are
likely to be measuring a single effect. The association at
CXCR1_rs2234671 is robust to application of a strict
Bonferroni correction for 3 independent (i.e. r2 < 0.8)
Table 2 Details of polymorphisms genotyped and the minor allele frequency (MAF) of variants in the Indian study
population
SNP Identity Location Amino Acid Change Physical Position1 (bp) Alleles2 Strand MAF
CXCR2_rs4674259 5’UTR - 218991005 T/C - 0.43
CXCR1_rs2234671 Exon1 S276T 219029108 G/C - 0.16
CXCR1_rs3138060 Intron1 - 219031500 C/G - 0.12
1 Physical positions of markers are given according to Build 37.1 of the human genome; 2Major > minor alleles for this Indian population; All 3 SNPs were in HWE
in both unaffected founders of families and in controls for the replication study.
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SNPs genotyped, which requires a significance cut-off of
P ≤ 0.017 (i.e. P = 0.05/3).
Evidence for an association between Indian VL and
SNPs at CXCR1, which was consistent with data for
CL/ML from Brazil [16], prompted us to pursue two
further avenues of investigation. In so doing, we did
not discount the possibility that CXCR2 might play a
role, since the D’ measure (Additional File 2; Figure
S2) indicates strong LD across the CXCR1/2 SNPs for
this sample (D’ = 0.98 and 0.91). First, we looked at
expression levels of CXCR1/CXCR2 in mRNA from
splenic aspirates from 19 patients as paired samples
taken pre- and post-treatment for VL (Figure 1). This
demonstrated that CXCR2, but not CXCR1, is signifi-
cantly (P = 0.021) reduced in expression in pre-treat-
ment samples compared to post-treatment recovery
samples, indicating that a deficiency in expression of
CXCR2 might contribute to VL disease. Down regula-
tion of CXCR2, but not CXCR1, was similarly observed
in PMN from patients with pulmonary tuberculosis
[31]. Secondly, we carried out a comprehensive replica-
tion of the association study in a much larger popula-
tion-based case-control sample (Table 1) from the
same region of Bihar State in India. Logistic regression
analysis (Table 4) under an additive model of inheri-
tance showed association between VL and SNPs
CXCR2_rs4674259 (OR = 1.15, 95%CI = 1.01-1.31, P =
0.027) and CXCR1_rs3138060 (OR = 1.25, 95%CI =
1.02-1.53, P = 0.028), but not with CXCR1_rs2234671.
Effect sizes (OR) are small, as is common in complex
communicable or non-communicable diseases [32].
Significance was retained when either religion
Table 3 Family-based association analysis between CXCR1/CXCR2 and VL
Common Designation Allele Allele
frequency
# Fam S E(S) Var(S) Z P
CXCR2_rs4674259 T 0.53 105 196 194 57.313 0.216 0.829
CXCR2_rs4674259 C 0.47 105 184 186 57.313 -0.216 0.829
CXCR1_rs2234671 G 0.85 69 181 165 31.519 2.935 0.003
CXCR1_rs2234671 C 0.15 69 61 77 31.519 -2.935 0.003
CXCR1_rs3138060 G 0.12 49 49 59 22.187 -2.222 0.026
CXCR1_rs3138060 C 0.88 49 133 122 22.187 2.222 0.026
Single point FBAT analysis under an additive model of inheritance for associations between CXCR1/CXCR2 polymorphisms and VL in the primary family-based
sample set. # Fam = number of families informative for the FBAT analysis; S and E(S) represent the observed and expected transmissions for that allele, Var(S) is
the variance. A positive Z score indicates association with disease; a negative Z score indicates the non-associated or protective allele or genotype. Bold indicates
significant associations at nominal P ≤ 0.05. The corrected P-value required to achieve significance taking account of 3 independent SNPs is P ≤ 0.017.
Figure 1 Relative expression of CXCR1 (A) and CXCR2 (B) mRNA in paired splenic aspirates from VL patients before (Day 0) and after
(Day 30) antileishmanial treatment. Individual as well as mean (± SEM) relative expression for each group is indicated. Paired Student’s t tests
show significant differences in expression of CXCR2 but not CXCR1 when Day 0 values were compared to Day 30 values.
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(CXCR2_rs4674259: OR = 1.15, 95%CI = 1.02-1.31, P =
0.028; CXCR1_rs3138060: OR = 1.26, 95%CI = 1.03-
1.53, P = 0.026) or caste (CXCR2_rs4674259: OR =
1.15, 95%CI = 1.01-1.32, P = 0.039; CXCR1_rs3138060:
OR = 1.25, 95%CI = 1.01-1.54, P = 0.037) was used as
a covariate to take account of population substructure.
Interestingly, although CXCR1_rs3138060 was the only
SNP directly replicated across primary and replication
samples, the same 3-SNP haplotype T_G_C (called on
the negative strand; frequency 0.42) was shown to be
the risk haplotype in both family- (Table 5; TRANS-
MIT; P = 0.014) and population- (Table 5; PLINK; OR
= 1.16, P = 0.028) samples (combined P = 0.002). The
2- and 3-SNP over-transmitted haplotypes were more
apparent in the family-based sample, which likely
reflects over-relatedness for this set of families from
this region of India where we showed previously that
consanguineal marriages were common [19]. These
haplotype results indicate that associations seen at
CXCR1 might be due to LD with regulatory poly-
morphisms that influence CXCR2 expression.
Together, the genetic and functional analyses favour a
role for CXCR2 in contributing to susceptibility to VL
in this region of India, although a role for CXCR1 can-
not be discounted.
The involvement of either CXCR1 or CXCR2 in VL is
of interest given recent observations on the different
roles they may play in chemotaxis and activation of
PMN in sites of infection [33], and the increasing recog-
nition of the importance of PMN in the VL disease pro-
cess [12,17]. Both are high affinity receptors for the
CXC chemokine IL-8, but CXCR2 is more promiscuous
in also binding a range of other CXC chemokines
(CXCL-1, 2, 3, 5, 6, and 7) which may play important
roles in directing a broader array of immune cells to
sites of infection in the visceral organs. Recent studies
[34] also show that, while neutralizing antibodies against
CXCR2 abolish neutrophil extracellular trap (NET) for-
mation, antibodies against CXCR1 have no effect. NETs
are formed by DNA fibers decorated with antimicrobial
proteins released from PMN upon activation. The
release of DNA NETs, decorated with elastases and his-
tones, by human PMN upon interaction with Leishma-
nia parasites has been shown to ensnare the parasite
and is leishmanicidal [10], adding to the potential
importance of PMN in innate immunity to leishmanial
infection.
Here we examined CXCR1 and CXCR2 as candidate
genes for susceptibility to VL in India. Whilst SNPs at
both loci were associated with VL, functional analysis of
expression in splenic aspirates together with a common
risk haplotype favour CXCR2 as the etiological gene reg-
ulating susceptibility to disease. Our data contribute to
increasing evidence for an important role for PMN in
directing the outcome of leishmanial infections in
humans.
Conclusions
From the results of this well-powered primary and repli-
cation genetic study, together with functional analysis of
gene expression, we conclude that CXCR2 plays a role
in determining outcome of VL in India.
Table 4 Population-based association analysis between CXCR1/CXCR2 and VL
Common Designation Allele Affected Unaffected OR L95 U95 P-values
CXCR2_rs4674259 T 840/1036 816/1160 1.15 1.01 1.31 0.027
CXCR1_rs2234671 G 286/1592 321/1657 0.92 0.77 1.10 0.384
CXCR1_rs3138060 C 197/1685 252/1732 1.25 1.02 1.53 0.028
Logistic regression analyses under an additive model for the replication sample of VL cases and controls. OR = odds ratio; L95 and U95 are lower and upper 95%
confidence intervals. Allele counts are shown for minor/major allele for affected and unaffected individuals. Bold indicates associations significant at nominal P ≤
0.05. The corrected P-value required to achieve significance taking account of 3 independent SNPs is P ≤ 0.017.
Table 5 Haplotype association analyses between CXCR1/CXCR2 and VL
Haplo Family Analysis Freq CXCR2_rs4674259 CXCR1_rs2234671 CXCR1_rs3138060
T.G TRANSMIT 0.41 c2 = 4.61; 1df; P = 0.032
_ G.C TRANSMIT 0.83 c2 = 10.27; 1df; P = 0.001
T.G.C TRANSMIT 0.40 c2 = 5.98; 1df; P = 0.014
Haplo Case-Control Freq CXCR2_rs4674259 CXCR1_rs2234671 CXCR1_rs3138060
T.G PLINK 0.43 c2 = 4.34; 1df; P = 0.037
_ G.C PLINK 0.83 c2 = 1.29; 1df; P = 0.256
T.G.C PLINK 0.42 c2 = 4.99; 1df; P = 0.025
Chi-squared (c2), degrees of freedom (df) and P-values for risk associated (over-transmitted) haplotypes for the 3 SNPs as determined in TRANSMIT for the family-
based primary sample, and in PLINK for the case-control replication sample. Bold indicates significant associations at nominal P ≤ 0.05. Haplotypes are called on
the negative strand across the 3 SNPs.
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Additional material
Additional file 1: Figure S1. Graphical representation of pairwise D’ and
r2 LD measures across CXCR1 and CXCR2 in the HapMap CHB/JPT
populations demonstrating large LD blocks tagged by SNPs
CXCR1_rs3138060 and CXCR2_rs4674259 genotyped as tag-SNPs in the
study.
Additional file 2: Figure S2. Graphical representation of pairwise D’ and
r2 LD measures across 3 SNPs genotyped in the study.
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